Ascom Supplies Complete Alerts and Nurse Call Solution to New Finnish Hospital
“This is a particularly exciting project,” says Ari-Pekka Tenko, Sales Director at Ascom Finland. “The new Espoo Hospital is a pioneering facility focusing on geriatric rehabilitation and on preparing elderly patients to return home following hospitalization. It employs the very latest technical resources, and combines them with forward-thinking architecture and care delivery. It’s a perfect setting for an advanced Ascom solution.”
The Ascom solution for Espoo Hospital includes Ascom nurse call with Multiple Medical Alarm integration (MMA), Ascom Unite software, and almost 100 Ascom Myco handsets – smartphones specially designed for Healthcare. Every room is equipped with MMA that enables connection to infusion pumps, saturation meters and other equipment, as well as intelligent alarm forwarding to caregivers.
“The new Espoo Hospital features 270 single-patient rooms,” adds Tenko. “This helps control hospital infections, and contributes to restful healing, but it also means caregivers have to be reachable wherever they are. And that’s exactly what the Ascom Myco does—it keeps mobile staff connected to patients, colleagues, and medical devices.”
According to Jari Eriksson, who coordinated ICT projects at the hospital, Ascom was chosen primarily because of the Ascom Myco and its potential to support applications customized to the hospital’s specific requirements. “The Ascom Myco lets us design hospital workflows in a completely new way—a way simply not possible with other types of communication systems.”
Mobility and openness are hallmarks of the new Espoo Hospital. “The very architecture of this facility fights against institutionalization,” comments Jorma Teittinen, the hospital’s Medical Director. “Open any door, and you are there—no more endless corridors. Our care model, too, is fluid and mobile. Care and support will follow patients home in the form of remote access and home visits.”
The new Espoo Hospital has a staff of 403 Healthcare professionals, and opened for patients on March 6. “We’re thrilled to see our solution finally put to work,” says Tenko. “There’s something especially gratifying about helping to provide the best care possible to elderly patients—they’ve worked hard for us. Now we can work for them.”
Ascom is a global solutions provider focused on healthcare ICT and mobile workflow solutions. The vision of Ascom is to close digital information gaps allowing for the best possible decisions – anytime and anywhere. Ascom’s mission is to provide mission-critical, real-time solutions for highly mobile, ad hoc, and time-sensitive environments. Ascom uses its unique product and solutions portfolio and software architecture capabilities to devise integration and mobilization solutions that provide truly smooth, complete and efficient workflows for healthcare as well as for industry and retail sectors.
Ascom is headquartered in Baar (Switzerland), has subsidiaries in 15 countries and employs around 1,200 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.
Ascom (Finland) Ltd.
Phone: +358 40 500 9904
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
EXCLUSIVE-GROUP19.10.2017 10:02 | pressemeddelelse
Exclusive Group Adds Mellanox to BigTec Portfolio
DUCO19.10.2017 09:03 | pressemeddelelse
More Firms Select Duco for Mandatory MiFID II Reconciliation
SIAE-MICROELETTRONICA19.10.2017 09:02 | pressemeddelelse
SIAE MICROELETTRONICA Successfully Tests The SDN Application iVeritas in Telefónica Deutschland’s SDN Live Wireless Network
NV-RIMINI-STREET,-INC.19.10.2017 00:02 | pressemeddelelse
Rimini Street Expands Investment and Operations in Europe
CA-GILEAD-SCIENCES18.10.2017 23:45 | pressemeddelelse
Kite’s Yescarta™ (Axicabtagene Ciloleucel) Becomes First CAR T Therapy Approved by the FDA for the Treatment of Adult Patients With Relapsed or Refractory Large B-Cell Lymphoma After Two or More Lines of Systemic Therapy
NY-IFF18.10.2017 22:18 | pressemeddelelse
IFF Launches Re-Imagine…™ Programs to Tap Unmet Consumer Opportunities, Speed Innovation
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum